Answers are grounded in this paper and cite their sources.
A series of novel 3,6-disubstituted pyridazine derivatives were designed, synthesized, and biologically evaluated as preclinical anticancer candidates. Compound
No takes yet. Share an insight, caveat, or question.
Shaalan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: